VMD

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

Wall Street analysts forecast VMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VMD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Viemed Healthcare Inc revenue for the last quarter amounts to 71.91M USD, increased 23.98 % YoY.

Viemed Healthcare Inc. EPS for the last quarter amounts to 0.09 USD, decreased -10.00 % YoY.

Viemed Healthcare Inc (VMD) has 1179 emplpoyees as of December 15 2025.

Today VMD has the market capitalization of 274.49M USD.